LabCorp is Scheduled to Present at the 33rd Annual J.P. Morgan Healthcare Conference

BURLINGTON, N.C. --(BUSINESS WIRE)--Jan. 6, 2015-- Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) today announced that David P. King , Chairman and Chief Executive Officer, is scheduled to speak at the 33 rd Annual J.P. Morgan Healthcare Conference in San Francisco, CA.

Conversion Right Triggered for LabCorp’s Zero Coupon Convertible Subordinated Notes Due 2021

BURLINGTON, N.C.--(BUSINESS WIRE)--Jan. 2, 2015-- Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) announced today that its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) may be converted as set forth below.

LabCorp Introduces a Test to Identify Enterovirus D-68 (EV-D68)

BURLINGTON, N.C. --(BUSINESS WIRE)--Dec. 18, 2014-- Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) announced today the availability of a reflex test to identify enterovirus D68 (EV-D68), which is associated with severe respiratory illness that primarily affects children.

LabCorp Named Laboratory Service Provider of the Pro Football Legends

MOUNT LAUREL, N.J. & BURLINGTON, N.C. --(BUSINESS WIRE)--Dec. 17, 2014-- Pro Football Legends, the commercial marketing arm of the National Football League Alumni, Inc. (NFL Alumni) and Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) are pleased to announce that they have

Hart-Scott-Rodino Waiting Period Expires for LabCorp Acquisition of Covance

BURLINGTON, N.C. --(BUSINESS WIRE)--Dec. 16, 2014-- Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) and Covance Inc. ( Covance ) (NYSE: CVD) jointly announced today the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, or HSR Act,

LabCorp Announces Acquisition of Bode Technology

Acquisition expands LabCorp’s forensic DNA testing and relationship analysis capabilities BURLINGTON, N.C. --(BUSINESS WIRE)--Dec. 5, 2014-- Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) today announced the completion of its acquisition of Bode Technology Group, Inc.

LabCorp Completes Acquisition of LIPOSCIENCE

BURLINGTON, N.C. --(BUSINESS WIRE)--Nov. 21, 2014-- Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) today announced the completion of its acquisition of LIPOSCIENCE, Inc. (NASDAQ:LPDX), effective November 20, 2014 . At a special meeting held on November 20, 2014 , LIPOSCIENCE’s

LabCorp to Acquire Covance for Approximately $5.6 Billion, Creating World’s Leading Healthcare Diagnostics Company

Covance shareholders to receive cash and LabCorp shares currently valued at $105.12 per Covance share Combination creates comprehensive healthcare diagnostics company offering customers end-to-end solutions for drug and diagnostics development and commercialization Transaction expected to be

Laboratory Corporation of America® Holdings Announces 2014 Third Quarter Results and Increases 2014 EPS Guidance

Strong volume growth drives sales of $1.55 billion Diluted EPS of $1.59 ; Adjusted EPS of $1.80 Operating Cash Flow of $176 million ; Free Cash Flow of $123 million 2014 Adjusted EPS guidance raised to $6.70 - $6.80 BURLINGTON, N.C. --(BUSINESS WIRE)--Oct.

LabCorp Introduces HIV-1 Next Generation Sequencing Assay to Support Drug Regimen Changes in HIV Suppressed Patients

GenoSure Archive SM is the first genotypic drug resistance assay to interrogate HIV-1 DNA BURLINGTON, N.C. --(BUSINESS WIRE)--Oct. 20, 2014-- Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) and Monogram Biosciences, Inc. , part of the LabCorp Specialty Testing Group , today